This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Technion Research & Development Foundation Ltd. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Gal Eidelsztein: Innovator in Predicting Ventricular Fibrillation
Introduction
Gal Eidelsztein is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of medical technology, particularly in the prediction of ventricular fibrillation. His innovative approach utilizes machine learning algorithms to enhance the accuracy of predicting critical heart events.
Latest Patents
Eidelsztein holds a patent for a method of predicting ventricular fibrillation. This method involves training a machine learning algorithm on a dataset that includes heart rate variability parameters. The training set comprises samples that represent ventricular fibrillation events, along with associated labels that indicate periods of time leading up to these events. At the inference stage, the algorithm receives target heart rate variability parameters from a subject and predicts the onset time of a ventricular fibrillation event.
Career Highlights
Gal Eidelsztein is affiliated with the Technion Research & Development Foundation Limited, where he applies his expertise in machine learning and medical technology. His work is pivotal in advancing predictive healthcare solutions that can potentially save lives.
Collaborations
Eidelsztein collaborates with talented individuals such as Yael Yaniv and Noam Keidar. Their combined efforts contribute to the development of innovative solutions in the medical field.
Conclusion
Gal Eidelsztein is a pioneering inventor whose work in predicting ventricular fibrillation showcases the intersection of technology and healthcare. His contributions are vital for improving patient outcomes and advancing medical research.
